| 2004 |
WDR26 is a novel WD40 repeat, Gβ-like protein that, when overexpressed, suppresses MAPK signaling by inhibiting ELK-1 and c-fos SRE transcriptional activities mediated by MEKK1, acting as a negative regulator of the MAPK pathway. |
Overexpression in cells with transcriptional reporter assays (ELK-1 and SRE-driven luciferase) downstream of MEKK1 |
Journal of cellular biochemistry |
Medium |
15378603
|
| 2011 |
WDR26 directly binds free Gβγ in vitro and forms a complex with endogenous Gβγ in SDF1α-stimulated Jurkat T cells; WDR26 is required for Gβγ-dependent PLCβ and PI3K activation and for leukocyte chemotaxis. WDR26 also controls RACK1 (a negative regulator) binding to Gβγ. |
In vitro direct binding assay, co-immunoprecipitation with endogenous Gβγ, siRNA knockdown with functional readouts (PLCβ/PI3K activation, chemotaxis, in vivo homing in SCID mice), WDR26 deletion mutant expression |
The Journal of biological chemistry |
High |
22065575
|
| 2013 |
WDR26 functions as a scaffolding protein that directly binds both Gβγ and PLCβ2 (with overlapping but non-identical binding sites on Gβ1γ2), forms higher-order oligomers through its LisH-CTLH and WD40 domains, and promotes PLCβ2 membrane translocation and interaction with Gβγ, thereby enhancing PLCβ2 activation in leukocytes. |
Direct binding assays, co-immunoprecipitation, domain-mapping with deletion mutants, fluorescence imaging of PLCβ2 translocation, functional PLCβ2 activity assays |
The Journal of biological chemistry |
High |
23625927
|
| 2016 |
WDR26 serves as a scaffold downstream of GPCR stimulation to assemble a specific signaling complex consisting of Gβγ, PI3Kβ, and AKT2, selectively promoting GPCR- (but not EGF receptor-) stimulated PI3K/AKT signaling in breast cancer cells. Disrupting this complex via WDR26 mutants abrogated PI3K/AKT activation and tumor growth/metastasis in an orthotopic xenograft model. |
siRNA knockdown, overexpression of WDR26 mutants disrupting complex assembly, signaling assays (pAKT, pPI3K), orthotopic xenograft mouse model |
Oncotarget |
High |
26895380
|
| 2016 |
WDR26 binds Axin1 and acts as a negative regulator of canonical Wnt signaling by promoting ubiquitination and degradation of β-catenin; WDR26/Axin interaction is required for this effect. |
Co-immunoprecipitation (WDR26–Axin1 interaction), β-catenin ubiquitination assay, Wnt reporter assay, WDR26 overexpression/knockdown |
FEBS letters |
Medium |
27098453
|
| 2016 |
WDR26 promotes hypoxia-induced mitophagy in cardiomyocytes (H9c2 cells) by increasing mitochondrial membrane potential and facilitating Parkin translocation to mitochondria, leading to increased mitochondrial protein ubiquitination. |
WDR26 overexpression/knockdown in H9c2 cells under hypoxia, Parkin translocation imaging, mitochondrial membrane potential measurement, ubiquitination assay |
Acta biochimica et biophysica Sinica |
Medium |
27797717
|
| 2020 |
Wdr26, as part of the GID/CTLH E3 ubiquitin ligase complex, regulates ubiquitination and proteasomal degradation of nuclear proteins including lamin B during terminal erythropoiesis; loss of Wdr26 impairs lamin B degradation, blocks nuclear opening formation, and causes defective nuclear condensation and enucleation. |
Wdr26 knockout in mouse erythroblasts (enucleation defects), zebrafish knockdown (anemia), ubiquitination assays for lamin B, lamin B protein level measurement, CTLH/GID complex co-immunoprecipitation |
Blood |
High |
31945154
|
| 2009 |
WDR26 overexpression suppresses H2O2-induced cell death in SH-SY5Y neuroblastoma cells and downregulates AP-1 transcriptional activity during oxidative stress; conversely, antisense ODN knockdown of WDR26 enhances H2O2-induced cell death. |
Overexpression and antisense ODN knockdown, cell viability assay, AP-1 luciferase reporter assay |
Neuroscience letters |
Low |
19446606
|
| 2012 |
WDR26 localizes to mitochondria and inhibits cytochrome c release from mitochondria, thereby suppressing apoptosis in H9c2 cardiomyocytes under oxidative stress. |
Subcellular fractionation/localization assay, cytochrome c release assay, WDR26 overexpression with H2O2 treatment, apoptosis readout |
Free radical research |
Low |
22448652
|
| 2024 |
WDR26 acts as a non-canonical substrate receptor within the CTLH E3 complex to bind NMNAT1 via an internal basic degron motif and mediate its ubiquitylation and cellular degradation independently of canonical GID/CTLH substrate receptors. YPEL5 inhibits this process by N-terminal degron mimicry of NMNAT1. Cryo-EM structures of NMNAT1- and YPEL5-bound WDR26-CTLH E3 complexes were determined. |
Cryo-EM structure determination, in vitro ubiquitylation assay, co-immunoprecipitation, degron mutagenesis, cellular degradation assays, YPEL5 knockout/overexpression |
Molecular cell |
High |
38759627
|
| 2024 |
SKDEAS-associated WDR26 mutations impair CTLH E3 complex assembly and function; WDR26 homodimers bridge two core-CTLH E3 complexes to form supramolecular oval-shaped assemblies, mediates CTLH E3 binding to YPEL5, and functions as substrate receptor for transcriptional repressor HBP1. 15 of 16 patient-derived mutants impaired at least one of these functions. |
Structural modeling of WDR26, complementation assays in WDR26-KO cells engineered to lack CTLH supramolecular assemblies, functional assays for complex assembly, YPEL5 binding, and HBP1 substrate receptor activity |
FEBS letters |
High |
38575527
|
| 2024 |
WDR26 and muskelin β-propeller proteins compete for binding to the CTLH complex scaffold in an interchangeable manner, forming separate WDR26- or muskelin-containing complexes with distinct proteomes. CTLH E3 ligase activity in HeLa cells is dictated by the interplay between WDR26 and muskelin; muskelin protein turnover is a major ubiquitin-dependent degradation event dependent on the CTLH complex. |
Proteomic experiments (mass spectrometry), WDR26 and muskelin knockout cell lines, co-immunoprecipitation, ubiquitin assays, mTOR inhibition experiments |
Communications biology |
High |
39702571
|
| 2025 |
The CTLH-WDR26 E3 complex mediates ubiquitin-dependent degradation of UCK2 (rate-limiting enzyme of pyrimidine salvage pathway) during mTORC1 inhibition; UCK1, an isoform of UCK2, affects UCK2 turnover by influencing its subcellular localization. |
mTORC1 inhibition (rapamycin) with WDR26/CTLH knockdown/knockout, UCK2 half-life/degradation assays, ubiquitination assays, cellular localization experiments |
Cell reports |
High |
39808525
|
| 2026 |
Wdr26 haploinsufficiency in mice stabilizes RUNX1T1 (a transcriptional coactivator) by impairing its ubiquitination and proteasomal degradation via the CTLH complex, leading to elevated MAP2 and disrupted dendritic/synaptic architecture. AAV-shRNA knockdown of Runx1t1 in neonatal Wdr26+/- mice reversed MAP2 overexpression and behavioral deficits. |
Wdr26 heterozygous KO mouse model, RUNX1T1 ubiquitination assay, MAP2 protein level measurement, AAV-shRNA rescue experiment, behavioral tests |
The Journal of clinical investigation |
High |
42138082
|
| 2025 |
Missense variants in WDR26 associated with Skraban-Deardorff syndrome markedly reduce WDR26 protein levels through accelerated proteasomal degradation (reversed by proteasome inhibitor), while a frameshift variant reduces WDR26 mRNA via nonsense-mediated decay; both mechanisms result in loss of function and impaired cell proliferation. |
Cycloheximide chase, proteasome inhibitor treatment, mRNA stability assays, lymphoblastoid cell proliferation assay with patient-derived variants |
European journal of medical research |
Medium |
40826479
|